Botulinum Toxin for Scalp Dysesthesia

Scalp dysesthesia is characterized by abnormal cutaneous sensations such as burning, stinging, or itching of the scalp. This condition is particularly challenging to manage as there is a lack of well-established treatments. By limiting release of neurotransmitters such as substance P, glutamate, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Kevin, Lin, Matthew James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153304/
https://www.ncbi.nlm.nih.gov/pubmed/35655646
http://dx.doi.org/10.4103/JCAS.JCAS_197_20
_version_ 1784717818283950080
author Phan, Kevin
Lin, Matthew James
author_facet Phan, Kevin
Lin, Matthew James
author_sort Phan, Kevin
collection PubMed
description Scalp dysesthesia is characterized by abnormal cutaneous sensations such as burning, stinging, or itching of the scalp. This condition is particularly challenging to manage as there is a lack of well-established treatments. By limiting release of neurotransmitters such as substance P, glutamate, and calcitonin gene-related peptide, botulinum toxin may have a role in ameliorating neuropathic pain. We report a unique case in which botulinum toxin was used in the management of scalp dysesthesia.
format Online
Article
Text
id pubmed-9153304
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91533042022-06-01 Botulinum Toxin for Scalp Dysesthesia Phan, Kevin Lin, Matthew James J Cutan Aesthet Surg Case Report Scalp dysesthesia is characterized by abnormal cutaneous sensations such as burning, stinging, or itching of the scalp. This condition is particularly challenging to manage as there is a lack of well-established treatments. By limiting release of neurotransmitters such as substance P, glutamate, and calcitonin gene-related peptide, botulinum toxin may have a role in ameliorating neuropathic pain. We report a unique case in which botulinum toxin was used in the management of scalp dysesthesia. Wolters Kluwer - Medknow 2022 /pmc/articles/PMC9153304/ /pubmed/35655646 http://dx.doi.org/10.4103/JCAS.JCAS_197_20 Text en Copyright: © 2022 Journal of Cutaneous and Aesthetic Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Phan, Kevin
Lin, Matthew James
Botulinum Toxin for Scalp Dysesthesia
title Botulinum Toxin for Scalp Dysesthesia
title_full Botulinum Toxin for Scalp Dysesthesia
title_fullStr Botulinum Toxin for Scalp Dysesthesia
title_full_unstemmed Botulinum Toxin for Scalp Dysesthesia
title_short Botulinum Toxin for Scalp Dysesthesia
title_sort botulinum toxin for scalp dysesthesia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153304/
https://www.ncbi.nlm.nih.gov/pubmed/35655646
http://dx.doi.org/10.4103/JCAS.JCAS_197_20
work_keys_str_mv AT phankevin botulinumtoxinforscalpdysesthesia
AT linmatthewjames botulinumtoxinforscalpdysesthesia

Ejemplares similares